Gmo Emerging is trading at 14.45 as of the 26th of November 2024; that is 0.28 percent increase since the beginning of the trading day. The fund's open price was 14.41. Gmo Emerging has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Gmo Emerging Markets are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Under normal circumstances at least 80 percent of the funds net assets directly and indirectly in companies tied economically to markets that are not treated as developed markets in the MSCI World Index, with the exception of China . It may also invest In U.S. More on Gmo Emerging Markets
Gmo Emerging Markets [GMAQX] is traded in USA and was established 26th of November 2024. Gmo Emerging is listed under GMO category by Fama And French industry classification. The fund is listed under Diversified Emerging Mkts category and is part of GMO family. Gmo Emerging Markets currently has accumulated 79.23 M in assets under management (AUM) with no minimum investment requirements with the current yeild of 0.07%.
Check Gmo Emerging Probability Of Bankruptcy
Gmo Emerging financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Emerging security.